Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, 138-736, Songpa-gu, Seoul, 05505, Korea.
Department of Radiology, Ajou University School of Medicine and Graduate School of Medicine, Ajou University Hospital, Yeongtong-gu, Suwon, 16499, Korea.
BMC Med Imaging. 2019 Nov 15;19(1):89. doi: 10.1186/s12880-019-0378-5.
To facilitate translational drug development for liver fibrosis, preclinical trials need to be run in parallel with clinical research. Liver function estimation by gadoxetate-enhanced dynamic contrast-enhanced MRI (DCE-MRI) is being established in clinical research, but still rarely used in preclinical trials. We aimed to evaluate feasibility of DCE-MRI indices as translatable biomarkers in a liver fibrosis animal model.
Liver fibrosis was induced in Sprague-Dawley rats by thioacetamide (200 mg, 150 mg, and saline for the high-dose, low-dose, and control groups, respectively). Subsequently, DCE-MRI was performed to measure: relative liver enhancement at 3-min (RLE-3), RLE-15, initial area-under-the-curve until 3-min (iAUC-3), iAUC-15, and maximum-enhancement (Emax). The correlation coefficients between these MRI indices and the histologic collagen area, indocyanine green retention at 15-min (ICG-R15), and shear wave elastography (SWE) were calculated. Diagnostic performance to diagnose liver fibrosis was also evaluated by receiver-operating-characteristic (ROC) analysis.
Animal model was successful in that the collagen area of the liver was the largest in the high-dose group, followed by the low-dose group and control group. The correlation between the DCE-MRI indices and collagen area was high for iAUC-15, Emax, iAUC-3, and RLE-3 but moderate for RLE-15 (r, - 0.81, - 0.81, - 0.78, - 0.80, and - 0.51, respectively). The DCE-MRI indices showed moderate correlation with ICG-R15: the highest for iAUC-15, followed by iAUC-3, RLE-3, Emax, and RLE-15 (r, - 0.65, - 0.63, - 0.62, - 0.58, and - 0.56, respectively). The correlation coefficients between DCE-MRI indices and SWE ranged from - 0.59 to - 0.28. The diagnostic accuracy of RLE-3, iAUC-3, iAUC-15, and Emax was 100% (AUROC 1.000), whereas those of RLE-15 and SWE were relatively low (AUROC 0.777, 0.848, respectively).
Among the gadoxetate-enhanced DCE-MRI indices, iAUC-15 and iAUC-3 might be bidirectional translatable biomarkers between preclinical and clinical research for evaluating histopathologic liver fibrosis and physiologic liver functions in a non-invasive manner.
为了促进肝纤维化的药物转化研究,需要同时进行临床研究和临床前试验。钆塞酸增强的动态对比增强磁共振成像(DCE-MRI)用于评估肝功能,目前已在临床研究中建立,但在临床前试验中仍很少使用。我们旨在评估 DCE-MRI 指数作为肝纤维化动物模型中可转化生物标志物的可行性。
采用硫代乙酰胺(高剂量组 200mg,低剂量组 150mg,对照组 200mg)诱导 Sprague-Dawley 大鼠肝纤维化。随后进行 DCE-MRI 测量:3 分钟时的相对肝增强(RLE-3)、RLE-15、3 分钟内的初始曲线下面积(iAUC-3)、iAUC-15 和最大增强(Emax)。计算这些 MRI 指数与组织学胶原面积、15 分钟时吲哚菁绿保留率(ICG-R15)和剪切波弹性成像(SWE)之间的相关系数。通过受试者工作特征(ROC)分析评估这些 DCE-MRI 指数诊断肝纤维化的诊断性能。
动物模型成功建立,肝胶原面积最大的是高剂量组,其次是低剂量组和对照组。iAUC-15、Emax、iAUC-3 和 RLE-3 与胶原面积的相关性较高,而 RLE-15 的相关性适中(r 值分别为-0.81、-0.81、-0.78、-0.80 和-0.51)。DCE-MRI 指数与 ICG-R15 呈中度相关:iAUC-15 相关性最高,其次是 iAUC-3、RLE-3、Emax 和 RLE-15(r 值分别为-0.65、-0.63、-0.62、-0.58 和-0.56)。DCE-MRI 指数与 SWE 之间的相关系数范围为-0.59 至-0.28。RLE-3、iAUC-3、iAUC-15 和 Emax 的诊断准确性为 100%(AUROC 1.000),而 RLE-15 和 SWE 的诊断准确性相对较低(AUROC 分别为 0.777、0.848)。
在钆塞酸增强 DCE-MRI 指数中,iAUC-15 和 iAUC-3 可能是用于评估肝纤维化组织病理学和生理肝功能的临床前和临床研究之间的双向可转化生物标志物。